CH Biotech R&D Co., Ltd. (TPE:6534)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
86.30
-1.70 (-1.93%)
At close: Mar 27, 2026
Market Cap8.87B +1.5%
Revenue (ttm)1.82B +11.2%
Net Income464.00M -2.6%
EPS4.50 -2.4%
Shares Out102.80M
PE Ratio19.18
Forward PEn/a
Dividend4.80 (5.56%)
Ex-Dividend DateMar 26, 2026
Volume62,331
Average Volume380,355
Open87.00
Previous Close88.00
Day's Range86.30 - 87.50
52-Week Range71.10 - 123.50
Beta0.17
RSI51.48
Earnings DateMay 6, 2026

About CH Biotech R&D

CH Biotech R&D Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of agriculture chemicals in Taiwan, the United States, and internationally. It offers fertilizers, biostimulants, and plant growth regulators; and provides biotechnology services. The company was incorporated in 2013 and is headquartered in Nantou City, Taiwan. [Read more]

Sector Materials
Founded 2013
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 6534
Full Company Profile

Financial Performance

In 2025, CH Biotech R&D's revenue was 1.82 billion, an increase of 11.21% compared to the previous year's 1.64 billion. Earnings were 464.00 million, a decrease of -2.60%.

Financial Statements